• Explore /
  • Poster
  • / Multicenter phase Ib/ II study of biweekly trifluridine/tipiracil with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study).

Multicenter phase Ib/ II study of biweekly trifluridine/tipiracil with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study).

Abstract Poster

Authors

null

Masahito Kotaka

Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan

Masahito Kotaka , Hironaga Satake , Koji Oba , Yoshinori Kagawa , Hisateru Yasui , Masato Nakamura , Takanori Watanabe , Toshihiko Matsumoto , Takayuki Kii , Tetsuji Terazawa , Akitaka Makiyama , Nao Takano , Mitsuru Yokota , Yoshihiro Okita , Koreatsu Matoba , Hiroko Hasegawa , Akihito Tsuji , Naoki Nagata , Junichi Sakamoto , Takeshi Kato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000029198

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 647)

DOI

10.1200/JCO.2019.37.4_suppl.647

Abstract #

647

Poster Bd #

L12

Abstract Disclosures

Similar Posters

First Author: Hirokazu Shoji

First Author: Kayo Yasuda

First Author: Nieves Martinez Lago

First Author: Atsushi Ishiguro